Global and China Antihistamine Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Nov-2020
No. of pages: 143
Inquire Before Buying

Antihistamine Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antihistamine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Antihistamine Drugs market is segmented into

- Prescription-based

- Over-the-counter (OTC)

Segment by Application, the Antihistamine Drugs market is segmented into

- Hospital pharmacies

- Retail pharmacies

- Online pharmacies

Regional and Country-level Analysis

The Antihistamine Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Antihistamine Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Antihistamine Drugs Market Share Analysis

Antihistamine Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antihistamine Drugs business, the date to enter into the Antihistamine Drugs market, Antihistamine Drugs product introduction, recent developments, etc.

The major vendors covered:

- Bayer

- Almirall

- Meda Consumer Healthcare

- AstraZeneca

- Johnson & Johnson

- Novartis

- Sanofi

- Pfizer

- Boehringer Ingelheim

- Akorn

- Merck & Co.

- Teva Pharmaceutical

Global and China Antihistamine Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antihistamine Drugs Product Introduction
1.2 Market Segments
1.3 Key Antihistamine Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antihistamine Drugs Market Size Growth Rate by Type
1.4.2 Prescription-based
1.4.3 Over-the-counter (OTC)
1.5 Market by Application
1.5.1 Global Antihistamine Drugs Market Size Growth Rate by Application
1.5.2 Hospital pharmacies
1.5.3 Retail pharmacies
1.5.4 Online pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antihistamine Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antihistamine Drugs Revenue 2015-2026
2.1.2 Global Antihistamine Drugs Sales 2015-2026
2.2 Global Antihistamine Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Antihistamine Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Antihistamine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Antihistamine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Antihistamine Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Antihistamine Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Antihistamine Drugs Revenue Forecast by Region (2021-2026)
3 Global Antihistamine Drugs Competitor Landscape by Players
3.1 Global Top Antihistamine Drugs Sales by Manufacturers
3.1.1 Global Antihistamine Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Antihistamine Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Antihistamine Drugs Manufacturers by Revenue
3.2.1 Global Antihistamine Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Antihistamine Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antihistamine Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antihistamine Drugs Revenue in 2019
3.2.5 Global Antihistamine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antihistamine Drugs Price by Manufacturers
3.4 Global Antihistamine Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antihistamine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antihistamine Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antihistamine Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antihistamine Drugs Market Size by Type (2015-2020)
4.1.1 Global Antihistamine Drugs Sales by Type (2015-2020)
4.1.2 Global Antihistamine Drugs Revenue by Type (2015-2020)
4.1.3 Antihistamine Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antihistamine Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antihistamine Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antihistamine Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antihistamine Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antihistamine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antihistamine Drugs Market Size by Application (2015-2020)
5.1.1 Global Antihistamine Drugs Sales by Application (2015-2020)
5.1.2 Global Antihistamine Drugs Revenue by Application (2015-2020)
5.1.3 Antihistamine Drugs Price by Application (2015-2020)
5.2 Antihistamine Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antihistamine Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antihistamine Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antihistamine Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Antihistamine Drugs Market Size YoY Growth 2015-2026
6.1.1 China Antihistamine Drugs Sales YoY Growth 2015-2026
6.1.2 China Antihistamine Drugs Revenue YoY Growth 2015-2026
6.1.3 China Antihistamine Drugs Market Share in Global Market 2015-2026
6.2 China Antihistamine Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Antihistamine Drugs Players by Sales (2015-2020)
6.2.2 China Top Antihistamine Drugs Players by Revenue (2015-2020)
6.3 China Antihistamine Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Antihistamine Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Antihistamine Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Antihistamine Drugs Price by Type (2015-2020)
6.4 China Antihistamine Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Antihistamine Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Antihistamine Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Antihistamine Drugs Price Forecast by Type (2021-2026)
6.5 China Antihistamine Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Antihistamine Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Antihistamine Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Antihistamine Drugs Price by Application (2015-2020)
6.6 China Antihistamine Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Antihistamine Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Antihistamine Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Antihistamine Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Antihistamine Drugs Market Size YoY Growth 2015-2026
7.2 North America Antihistamine Drugs Market Facts & Figures by Country
7.2.1 North America Antihistamine Drugs Sales by Country (2015-2020)
7.2.2 North America Antihistamine Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Antihistamine Drugs Market Size YoY Growth 2015-2026
8.2 Europe Antihistamine Drugs Market Facts & Figures by Country
8.2.1 Europe Antihistamine Drugs Sales by Country
8.2.2 Europe Antihistamine Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antihistamine Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Antihistamine Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Antihistamine Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Antihistamine Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Antihistamine Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Antihistamine Drugs Market Facts & Figures by Country
10.2.1 Latin America Antihistamine Drugs Sales by Country
10.2.2 Latin America Antihistamine Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antihistamine Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Antihistamine Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Antihistamine Drugs Sales by Country
11.2.2 Middle East and Africa Antihistamine Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Antihistamine Drugs Products Offered
12.1.5 Bayer Recent Development
12.2 Almirall
12.2.1 Almirall Corporation Information
12.2.2 Almirall Description and Business Overview
12.2.3 Almirall Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Almirall Antihistamine Drugs Products Offered
12.2.5 Almirall Recent Development
12.3 Meda Consumer Healthcare
12.3.1 Meda Consumer Healthcare Corporation Information
12.3.2 Meda Consumer Healthcare Description and Business Overview
12.3.3 Meda Consumer Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Meda Consumer Healthcare Antihistamine Drugs Products Offered
12.3.5 Meda Consumer Healthcare Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Description and Business Overview
12.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca Antihistamine Drugs Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Antihistamine Drugs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Antihistamine Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Antihistamine Drugs Products Offered
12.7.5 Sanofi Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Antihistamine Drugs Products Offered
12.8.5 Pfizer Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Corporation Information
12.9.2 Boehringer Ingelheim Description and Business Overview
12.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Boehringer Ingelheim Antihistamine Drugs Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 Akorn
12.10.1 Akorn Corporation Information
12.10.2 Akorn Description and Business Overview
12.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Akorn Antihistamine Drugs Products Offered
12.10.5 Akorn Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer Antihistamine Drugs Products Offered
12.11.5 Bayer Recent Development
12.12 Teva Pharmaceutical
12.12.1 Teva Pharmaceutical Corporation Information
12.12.2 Teva Pharmaceutical Description and Business Overview
12.12.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Teva Pharmaceutical Products Offered
12.12.5 Teva Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antihistamine Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antihistamine Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Antihistamine Drugs Market Segments
Table 2. Ranking of Global Top Antihistamine Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antihistamine Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prescription-based
Table 5. Major Manufacturers of Over-the-counter (OTC)
Table 6. Global Antihistamine Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Antihistamine Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Antihistamine Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Antihistamine Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Antihistamine Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antihistamine Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Antihistamine Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Antihistamine Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Antihistamine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Antihistamine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihistamine Drugs as of 2019)
Table 16. Antihistamine Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Antihistamine Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Antihistamine Drugs Price (2015-2020) (USD/Unit)
Table 19. Antihistamine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Antihistamine Drugs Product Type
Table 21. Date of International Manufacturers Enter into Antihistamine Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Antihistamine Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Antihistamine Drugs Sales Share by Type (2015-2020)
Table 25. Global Antihistamine Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Antihistamine Drugs Revenue Share by Type (2015-2020)
Table 27. Antihistamine Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Antihistamine Drugs Sales Share by Type (2021-2026)
Table 29. Global Antihistamine Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Antihistamine Drugs Sales Share by Application (2015-2020)
Table 31. Global Antihistamine Drugs Sales Share by Application (2021-2026)
Table 32. Global Antihistamine Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Antihistamine Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Antihistamine Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Antihistamine Drugs Sales (K Units) of Key Companies (2015-2020)
Table 36. China Antihistamine Drugs Sales Share by Company (2015-2020)
Table 37. China Antihistamine Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. China Antihistamine Drugs Sales (K Units) by Type (2015-2020)
Table 39. China Antihistamine Drugs Sales Share by Type (2015-2020)
Table 40. China Antihistamine Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Antihistamine Drugs Price (K Units) by Type (2015-2020)
Table 42. China Antihistamine Drugs Sales (K Units) by Type (2021-2026)
Table 43. China Antihistamine Drugs Sales Share by Type (2021-2026)
Table 44. China Antihistamine Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Antihistamine Drugs Revenue Share by Type (2021-2026)
Table 46. China Antihistamine Drugs Price (K Units) by Type (2021-2026)
Table 47. China Antihistamine Drugs Sales (K Units) by Application (2015-2020)
Table 48. China Antihistamine Drugs Sales Share by Application (2015-2020)
Table 49. China Antihistamine Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Antihistamine Drugs Sales (K Units) by Application (2021-2026)
Table 51. China Antihistamine Drugs Sales Share by Application (2021-2026)
Table 52. China Antihistamine Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Antihistamine Drugs Revenue Share by Application (2021-2026)
Table 54. North America Antihistamine Drugs Sales by Country (2015-2020) (K Units)
Table 55. North America Antihistamine Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Antihistamine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Antihistamine Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Antihistamine Drugs Sales by Country (2015-2020) (K Units)
Table 59. Europe Antihistamine Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Antihistamine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Antihistamine Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Antihistamine Drugs Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Antihistamine Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Antihistamine Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Antihistamine Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Antihistamine Drugs Sales by Country (2015-2020) (K Units)
Table 67. Latin America Antihistamine Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Antihistamine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Antihistamine Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antihistamine Drugs Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Antihistamine Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antihistamine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Antihistamine Drugs Revenue Market Share by Country (2015-2020)
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Business Overview
Table 76. Bayer Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bayer Antihistamine Drugs Product
Table 78. Bayer Recent Development
Table 79. Almirall Corporation Information
Table 80. Almirall Description and Business Overview
Table 81. Almirall Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Almirall Product
Table 83. Almirall Recent Development
Table 84. Meda Consumer Healthcare Corporation Information
Table 85. Meda Consumer Healthcare Description and Business Overview
Table 86. Meda Consumer Healthcare Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Meda Consumer Healthcare Product
Table 88. Meda Consumer Healthcare Recent Development
Table 89. AstraZeneca Corporation Information
Table 90. AstraZeneca Description and Business Overview
Table 91. AstraZeneca Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. AstraZeneca Product
Table 93. AstraZeneca Recent Development
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Business Overview
Table 96. Johnson & Johnson Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Johnson & Johnson Product
Table 98. Johnson & Johnson Recent Development
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Business Overview
Table 101. Novartis Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Novartis Product
Table 103. Novartis Recent Development
Table 104. Sanofi Corporation Information
Table 105. Sanofi Description and Business Overview
Table 106. Sanofi Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Sanofi Product
Table 108. Sanofi Recent Development
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Business Overview
Table 111. Pfizer Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Pfizer Product
Table 113. Pfizer Recent Development
Table 114. Boehringer Ingelheim Corporation Information
Table 115. Boehringer Ingelheim Description and Business Overview
Table 116. Boehringer Ingelheim Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Boehringer Ingelheim Product
Table 118. Boehringer Ingelheim Recent Development
Table 119. Akorn Corporation Information
Table 120. Akorn Description and Business Overview
Table 121. Akorn Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Akorn Product
Table 123. Akorn Recent Development
Table 124. Merck & Co. Corporation Information
Table 125. Merck & Co. Description and Business Overview
Table 126. Merck & Co. Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Merck & Co. Product
Table 128. Merck & Co. Recent Development
Table 129. Teva Pharmaceutical Corporation Information
Table 130. Teva Pharmaceutical Description and Business Overview
Table 131. Teva Pharmaceutical Antihistamine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Teva Pharmaceutical Product
Table 133. Teva Pharmaceutical Recent Development
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Antihistamine Drugs Players
Table 138. Antihistamine Drugs Customers List
Table 139. Antihistamine Drugs Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Antihistamine Drugs Product Picture
Figure 2. Global Antihistamine Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription-based Product Picture
Figure 4. Over-the-counter (OTC) Product Picture
Figure 5. Global Antihistamine Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital pharmacies
Figure 7. Retail pharmacies
Figure 8. Online pharmacies
Figure 9. Antihistamine Drugs Report Years Considered
Figure 10. Global Antihistamine Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Antihistamine Drugs Sales 2015-2026 (K Units)
Figure 12. Global Antihistamine Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Antihistamine Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Antihistamine Drugs Sales Market Share by Region in 2019
Figure 15. Global Antihistamine Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Antihistamine Drugs Revenue Market Share by Region in 2019
Figure 17. Global Antihistamine Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Antihistamine Drugs Revenue in 2019
Figure 19. Antihistamine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Antihistamine Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Antihistamine Drugs Sales Market Share by Type in 2019
Figure 22. Global Antihistamine Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Antihistamine Drugs Revenue Market Share by Type in 2019
Figure 24. Global Antihistamine Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Antihistamine Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Antihistamine Drugs Sales Market Share by Application in 2019
Figure 27. Global Antihistamine Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Antihistamine Drugs Revenue Market Share by Application in 2019
Figure 29. China Antihistamine Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 30. China Antihistamine Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Antihistamine Drugs Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Antihistamine Drugs Players Market Share by Revenue in Antihistamine Drugs in 2019
Figure 33. China Antihistamine Drugs Revenue Share by Type (2015-2020)
Figure 34. China Antihistamine Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Antihistamine Drugs Revenue Share by Application (2015-2020)
Figure 36. China Antihistamine Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Antihistamine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Antihistamine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Antihistamine Drugs Sales Market Share by Country in 2019
Figure 40. North America Antihistamine Drugs Revenue Market Share by Country in 2019
Figure 41. U.S. Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Antihistamine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Antihistamine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Antihistamine Drugs Sales Market Share by Country in 2019
Figure 48. Europe Antihistamine Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Antihistamine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Antihistamine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Antihistamine Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Antihistamine Drugs Revenue Market Share by Region in 2019
Figure 63. China Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Antihistamine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Antihistamine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antihistamine Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Antihistamine Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Antihistamine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Antihistamine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Antihistamine Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Antihistamine Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Antihistamine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Antihistamine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Antihistamine Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs